FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Novo Nordisk Gains Updated Safety Outcomes Data on Tresiba

FDA approves a Novo Nordisk supplemental NDA for Tresiba (insulin degludec injection) 100 U/mL, 200 U/mL to include data from the DEVOTE safety outcom...

FDA General

Tamarack Recalls Eclipse Kratom-containing Powder

Tamarack recalls Eclipse Kratom-containing powder products because they have the potential to be contaminated with Salmonella.

Federal Register

Bulk Drug Use in Compounding Draft Guide

Federal Register notice: FDA makes available a draft guidance entitled Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Secti...

Human Drugs

FDA Guide on COPD Patient-reported Outcome Tool

FDA issues a guidance on Chronic Obstructive Pulmonary Disease: Use of the St. Georges Respiratory Questionnaire as a Patient-reported Outcome Assessm...

Medical Devices

Bioness Mobile App for Electrical Stimulation Device Cleared

FDA clears a Bioness 510(k) for the myBioness mobile app for use with its L300 Go System, a functional electrical stimulation system that offers 3D mo...

Human Drugs

DarioHealth 510(k) for Apple Lightning-enabled Glucose Meter

FDA clears a DarioHealth 510(k) for the companys Lightning-enabled version (Apple iPhone) of its Dario Blood Glucose Monitoring System.

Human Drugs

Illinois Jury Awards Man $3.2 Million in Androgel Suit

An Illinois federal jury finds AbbVie liable for injuries to an Oregon man allegedly caused by the companys testosterone replacement therapy AndroGel....

FDA General

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 3/23/2018.

Federal Register

Info Collection Extension for In Vivo Radiopharmaceuticals Regs

Federal Register notice: FDA sends for OMB approval an information collection extension for Regulations for In Vivo Radiopharmaceuticals Used for Diag...

Human Drugs

Draft Guide on Bulk Substances for Drug Compounding

FDA issues a draft guidance on Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and C...